This is the operating plan for June. It sets the positioning the creative leans on, the macro structure spend rolls up to, the weekly cadence the team ships against, and what we need from you to keep velocity. One-page sign-off at the end locks the month.
Reading order matters. The North Star fixes the positioning. The Diagnostic explains what we read in the account and why the plan responds the way it does. The Macro Structure carries that response into spend allocation. Everything after is execution.
Clinical-grade personal hygiene. Pro-tier formulation, daily-use ritual.
The positioning bridges two camps the category leaves open: mass personal-care commodities on one side, niche clinical brands like Augustinus Bader on the other. HygieneLab earns the middle by carrying pro-tier formulation credibility into a daily-use routine.
Founder voice is the credibility carrier. Kramer on-camera, science partner explanations, ingredient transparency. The creative does not chase trend hooks. It compounds the same credibility argument across cohorts.
We pulled the Motion account this week to baseline. Three findings shaped the plan below. They are why the macro structure looks the way it looks, not what we wish were true.
Finding one. The number we are currently optimizing against is almost certainly the wrong one. Trailing-30 immediate purchase ROAS reads 0.55x weighted across the top-spend ads. That number is bad in isolation. It is also incomplete. Six Angler LTV custom conversions live in the Meta workspace and none of them are surfacing in Motion. Whatever the HygieneLab team optimizes against internally on LTV is not the number we are reading. We have shipped a separate doc with seven questions to align on which Angler conversion is your headline metric. Until that gets wired in, the plan below is built against immediate purchase ROAS with the explicit caveat that the metric swaps when Angler lands.
Finding two. The spend mix is efficient where it should be scaling. The Clinical Believer cohort, the audience already convinced of the formula story, holds most of the budget today. The Clinical-Credible Daily Ritual cohort, the one that carries the strongest scaling argument because it reframes hygiene as a daily-ritual discipline rather than an episodic treatment, sits at minority share. That is upside down from where spend should sit if the goal is scale, not just efficient maintenance.
Finding three. The Performance Optimizer cohort is under one percent of spend. Runners, lifters, and recovery-focused users who treat personal hygiene as part of a training routine. The AND Persona Databank flags this segment (Hartman Performance) as systematically undermined in personal-care category. The cost-per-conversion math we have on the small spend behind this cohort suggests order-of-magnitude headroom if the creative carries the right credibility argument. June does not bet the month here, but does open the test.
What it tells us. The plan shifts weight from "convinced cohort holds" to "credible ritual scales." The M2 hero gets 45 to 50 percent of spend because that is the move the data says works at the volume we are trying to hit. M3 Cost-Per-Use Value is positioned as the test macro carrying enough weight to learn from. A single Performance Optimizer concept gets a test slot inside M1. Every macro below carries the data signal that put it there.
Three macros run in June, with a creator UGC layer threaded through. Spend allocation is the starting weight and shifts at the Week 2 read.
The signal. This cohort already converts efficiently. The discipline here is hold position, not expand it. The Performance Optimizer test slot sits inside this macro because it shares the same credibility-leaning hook structure.
Derm followers, ingredient researchers, skincare stackers extending discipline into hygiene. Holds the baseline efficient spend through the month.
The signal. The cohort that reframes hygiene as daily ritual carries the strongest credibility-to-scale path. The category positioning argument lives here. Today it is underweighted relative to what the data says it can absorb. June fixes that.
Pro-tier formulation framed as daily ritual, not occasional treatment. Kramer founder voice plus science partner explainers carry the weight. This is where the month is won or lost.
The signal. Price-conscious researcher behavior shows up in the engagement data but has not been served with concept work that earns the math. June validates whether this is a real cohort to invest behind or a tagging artifact.
Price-conscious researcher cohort. Cost-per-use math, whole-family efficiency, real-cost comparison. Sized to learn from, not to scale yet.
The signal. HygieneLab is the inaugural account on the Trybe creator platform. The bet is that whitelisted UGC slotted into the M1 and M2 hook structures lifts non-founder credibility without diluting the brand voice.
Eight creators briefed against the same hook structure as the founder content. Case study planned for release during June, separate from the performance work.
50 total assets across the month. The cadence below.
The named concepts shipping by Saturday June 7. Each carries the bet it is testing in parentheses after the hook lane.
Day-3 signal check: thumbstop rate and 3-second view-through compared against prior 30-day baseline. Day-7 read: spend allocation reweighted based on early winners; bets above are validated, killed, or held.
The numbers below are what we measured against and what we interpreted from them. They are not a scorecard; they are the read that produced the plan.
Reply to this doc with "Approved" to lock the month. Revisions handled within 24 hours via email, Slack, or reply.
Primary contact: Hayes Gotsick · hayes@andstudio.nyc · creative lead
Founder relationship: Robbie Hampton · robbie@andstudio.nyc